Renal-Limited Thrombotic Microangiopathy After Switching From Bevacizumab to Ramucirumab: A Case Report

BMC Nephrology - United Kingdom
doi 10.1186/s12882-018-1194-9
Full Text
Abstract

Available in full text

Categories
Nephrology
Date
Authors
Publisher

Springer Science and Business Media LLC

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy